Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome
Background: Irisin is a myokine potentially linked to insulin sensitivity. Polycystic ovarian syndrome (PCOS) is a prevalent hormonal condition defined by insulin resistance. Previous studies have reported elevated circulating irisin levels in adult females with PCOS. Objective: To examine the diffe...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Women's Health |
| Online Access: | https://doi.org/10.1177/17455057241302559 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846159282968461312 |
|---|---|
| author | Sadaf Majeed Hira Moin Riffat Shafi Sampana Fatima Tatheer Zahra Sarim Zafar |
| author_facet | Sadaf Majeed Hira Moin Riffat Shafi Sampana Fatima Tatheer Zahra Sarim Zafar |
| author_sort | Sadaf Majeed |
| collection | DOAJ |
| description | Background: Irisin is a myokine potentially linked to insulin sensitivity. Polycystic ovarian syndrome (PCOS) is a prevalent hormonal condition defined by insulin resistance. Previous studies have reported elevated circulating irisin levels in adult females with PCOS. Objective: To examine the differences in serum irisin levels between lean and obese adolescents and young adults with PCOS and their respective lean and obese controls and to explore the relationship between irisin levels and the metabolic and reproductive characteristics of the participants. Design: Cross-sectional study design. Methods: The study included 60 cases of PCOS and 60 controls. These participants were categorized based on their body mass index (BMI) into lean and obese. Fasting serum irisin levels, physical, metabolic, hormonal, and reproductive characteristics of the participants were measured. Results: Lean cases of PCOS had significantly elevated levels of fasting serum irisin (PCOS = 17.07 ± 5.61 ng/ml vs lean controls = 11.04 ± 7.51 ng/ml; p = 0.002), glucose, insulin, homeostasis model of assessment-insulin resistance index (HOMA-IR), luteinizing hormone (LH), estradiol, and testosterone and significantly lower levels of quantitative insulin sensitivity check index (QUICKI) compared to the lean controls. Obese cases of PCOS had significantly higher levels of fasting serum irisin (PCOS = 22.06 ± 3.83 ng/ml vs obese controls = 16.86 ± 6.74 ng/ml; p = 0.011), glucose, insulin, HOMA-IR, LH, estradiol, and testosterone and significantly lower levels of follicle-stimulating hormone (FSH) and QUICKI compared to obese controls. The findings revealed a significant positive correlation of serum irisin levels with BMI, glucose, insulin, HOMA-IR, LH, estradiol, and testosterone(all p -values < 0.001). There was also a significant positive correlation with triglycerides (TAGs) ( p = 0.001), total cholesterol ( p = 0.005), and low-density lipoprotein cholesterol ( p = 0.024). Additionally, there was a significant negative correlation with high-density lipoprotein cholesterol ( p = 0.001) and QUICKI ( p < 0.001) in the entire study cohort. Fasting serum glucose (β = 0.337, p = 0.029), TAGs (β = 0.249, p = 0.006), and LH (β = 0.382, p = 0.004) were positive predictors of serum irisin concentrations in the overall sample. Conclusion: Lean and obese adolescent and young adult cases of PCOS had significantly higher fasting serum irisin levels than their respective controls. Metabolic and reproductive traits of the participants also correlated with irisin. |
| format | Article |
| id | doaj-art-dfab3cb5bc0d4a78927695da8588a6c0 |
| institution | Kabale University |
| issn | 1745-5065 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Women's Health |
| spelling | doaj-art-dfab3cb5bc0d4a78927695da8588a6c02024-11-23T16:03:24ZengSAGE PublishingWomen's Health1745-50652024-11-012010.1177/17455057241302559Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndromeSadaf Majeed0Hira Moin1Riffat Shafi2Sampana Fatima3Tatheer Zahra4Sarim Zafar5Department of Biomedical Sciences, Dubai Medical College for Girls, Dubai, United Arab EmiratesDepartment of Physiology, NUST School of Health Sciences, National University of Sciences and Technology, Islamabad, PakistanDepartment of Physiology, Shifa Tameer-e-Millat University, Islamabad, PakistanDepartment of Physiology, Shalamar Medical and Dental College, Lahore, PakistanDepartment of Anatomy, Shifa Tameer-e-Millat University, Islamabad, PakistanDepartment of Physiology, NUST School of Health Sciences, National University of Sciences and Technology, Islamabad, PakistanBackground: Irisin is a myokine potentially linked to insulin sensitivity. Polycystic ovarian syndrome (PCOS) is a prevalent hormonal condition defined by insulin resistance. Previous studies have reported elevated circulating irisin levels in adult females with PCOS. Objective: To examine the differences in serum irisin levels between lean and obese adolescents and young adults with PCOS and their respective lean and obese controls and to explore the relationship between irisin levels and the metabolic and reproductive characteristics of the participants. Design: Cross-sectional study design. Methods: The study included 60 cases of PCOS and 60 controls. These participants were categorized based on their body mass index (BMI) into lean and obese. Fasting serum irisin levels, physical, metabolic, hormonal, and reproductive characteristics of the participants were measured. Results: Lean cases of PCOS had significantly elevated levels of fasting serum irisin (PCOS = 17.07 ± 5.61 ng/ml vs lean controls = 11.04 ± 7.51 ng/ml; p = 0.002), glucose, insulin, homeostasis model of assessment-insulin resistance index (HOMA-IR), luteinizing hormone (LH), estradiol, and testosterone and significantly lower levels of quantitative insulin sensitivity check index (QUICKI) compared to the lean controls. Obese cases of PCOS had significantly higher levels of fasting serum irisin (PCOS = 22.06 ± 3.83 ng/ml vs obese controls = 16.86 ± 6.74 ng/ml; p = 0.011), glucose, insulin, HOMA-IR, LH, estradiol, and testosterone and significantly lower levels of follicle-stimulating hormone (FSH) and QUICKI compared to obese controls. The findings revealed a significant positive correlation of serum irisin levels with BMI, glucose, insulin, HOMA-IR, LH, estradiol, and testosterone(all p -values < 0.001). There was also a significant positive correlation with triglycerides (TAGs) ( p = 0.001), total cholesterol ( p = 0.005), and low-density lipoprotein cholesterol ( p = 0.024). Additionally, there was a significant negative correlation with high-density lipoprotein cholesterol ( p = 0.001) and QUICKI ( p < 0.001) in the entire study cohort. Fasting serum glucose (β = 0.337, p = 0.029), TAGs (β = 0.249, p = 0.006), and LH (β = 0.382, p = 0.004) were positive predictors of serum irisin concentrations in the overall sample. Conclusion: Lean and obese adolescent and young adult cases of PCOS had significantly higher fasting serum irisin levels than their respective controls. Metabolic and reproductive traits of the participants also correlated with irisin.https://doi.org/10.1177/17455057241302559 |
| spellingShingle | Sadaf Majeed Hira Moin Riffat Shafi Sampana Fatima Tatheer Zahra Sarim Zafar Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome Women's Health |
| title | Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome |
| title_full | Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome |
| title_fullStr | Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome |
| title_full_unstemmed | Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome |
| title_short | Exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome |
| title_sort | exploring the role of irisin as a potential biomarker in adolescents and young adults with polycystic ovarian syndrome |
| url | https://doi.org/10.1177/17455057241302559 |
| work_keys_str_mv | AT sadafmajeed exploringtheroleofirisinasapotentialbiomarkerinadolescentsandyoungadultswithpolycysticovariansyndrome AT hiramoin exploringtheroleofirisinasapotentialbiomarkerinadolescentsandyoungadultswithpolycysticovariansyndrome AT riffatshafi exploringtheroleofirisinasapotentialbiomarkerinadolescentsandyoungadultswithpolycysticovariansyndrome AT sampanafatima exploringtheroleofirisinasapotentialbiomarkerinadolescentsandyoungadultswithpolycysticovariansyndrome AT tatheerzahra exploringtheroleofirisinasapotentialbiomarkerinadolescentsandyoungadultswithpolycysticovariansyndrome AT sarimzafar exploringtheroleofirisinasapotentialbiomarkerinadolescentsandyoungadultswithpolycysticovariansyndrome |